Shao-Lee Lin
CIK 1725092 · Chief Executive Officer · last filed 2026-07-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.10M
Companies
6
Total Filings
27
Lifetime Open-Market Net
-$264.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUE | Chief Executive Officer | 655,074 | $26.10 | $17.10M | $0 | 4 | 2026-07-30 |
| SRZNW | Director | — | $0.01 | — | $0 | 4 | 2025-05-15 |
| ACELYRIN, Inc. (SLRN) Delisted | Chief Executive Officer | 1,927,272 | $2.27 | $4.37M | -$264.6K | 7 | 2024-04-03 |
| Third Harmonic Bio, Inc. (THRD) Delisted | Director | — | $5.38 | — | $0 | 1 | 2022-10-27 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | — | — | — | $0 | 4 | 2020-09-28 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, Head of R&D and CSO | 109,668 | $116.30 | $12.75M | $0 | 6 | 2020-01-23 |
Recent Filings · Page 2 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-06 | ACELYRIN, Inc. (SLRN) Delisted | Other (J) | −1,029,511 | $0 | EDGAR |
| 2023-08-18 | ACELYRIN, Inc. (SLRN) Delisted | Grant (A) | +842,400 | $0 | EDGAR |
| 2023-05-19 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | ACELYRIN, Inc. (SLRN) Delisted | Mixed | +824,568 | -$8.32M | EDGAR |
| 2023-05-04 | — | Grant (A) | — | $0 | |
| 2022-10-27 | Third Harmonic Bio, Inc. (THRD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | SRZNW | Grant (A) | — | $0 | EDGAR |
| 2020-09-28 | Principia Biopharma Inc. (PRNB) Delisted | Disp (D) | — | $0 | EDGAR |
| 2020-06-08 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-23 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +3,413 | -$103.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.